N-[N'-(3',4'-dihydroxybenzoyl)-L-tyrosyl]-3,4-dihydroxybenzylamine | 300409-38-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-[N'-(3',4'-dihydroxybenzoyl)-L-tyrosyl]-3,4-dihydroxybenzylamine
• 英文别名: N-[(2S)-1-[(3,4-dihydroxyphenyl)methylamino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3,4-dihydroxybenzamide
• CAS: 300409-38-5
• 化学式: C₂₃H₂₂N₂O₇
• 分子量: 438.437
• InChiKey: ORZLTTIFCKNWOW-KRWDZBQOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  32
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  159
• 氢给体数：
  7
• 氢受体数：
  7

文献信息

• HYDROXYPHENYL DERIVATIVES WITH HIV INTEGRASE INHIBITORY PROPERTIES
  申请人：Pharmacor Inc.

  公开号：EP1165492A1

  公开（公告）日：2002-01-02
• US6362165B1
  申请人：——

  公开号：US6362165B1

  公开（公告）日：2002-03-26
• [EN] HYDROXYPHENYL DERIVATIVES WITH HIV INTEGRASE INHIBITORY PROPERTIES<br/>[FR] DERIVES D'HYDROXYPHENYLE POSSEDANT DES PROPRIETES INHIBITRICES DE L'INTEGRASE DU VIH
  申请人：PHARMACOR INC

  公开号：WO2000059867A1

  公开（公告）日：2000-10-12

  An hydroxphenyl derivative selected from the group consisting of a compound of formula (I), (II) and comprises a carboxylic acid group when a compound of formula (I) pharmaceutically acceptable salts thereof and when a compound of formula (I) comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein n is 1, 2 or 3, e is 1, 2 or 3, Hal represents a halogen atom (e.g. Cl, Br, F or I), p is 0, 1 or 2, r is 0, 1 or 2, X and X' each independently represents a single bond, a saturated straight or branched hydrocarbon group of 1 to 4 carbon atoms or a straigth or branched hydrocarbon group of 2 to 4 carbon atoms comprising a carbon to carbon double bond, Ra represents H or -CH3, and Raa represents H or -CH3; W may represent an amino acid residue or fragment. These compounds may be used to inhibit the activity of HIV integrase.